Detection of minimal residual disease in acute myeloid leukemia-Reference-Cited by-同舟云学术

Detection of minimal residual disease in acute myeloid leukemia

Published:2002-10 Issue:5 Volume:4 Page:398-402
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Baer Maria R.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-002-0033-z.pdf

Reference25 articles.

1. Strehl S, König M, Mann G, Haas OAL: Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia. Blood 2001, 97:805–808.

2. Jurcic JG, Nimer SD, Scheinberg DA, et al.: Prognostic significance of minimal residual disease detection and PML/RARa isoform type: long-term follow-up in acute promyelocytic leukemia. Blood 2001, 98:2651–2656. A series of patients studied by qualitative RT-PCR, with long-term follow-up.

3. Gameiro P, Vieira S, Carrara P, et al.: The PML-RARa transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica 2001, 86:577–585.

4. Tobal K, Moore H, Macheta M, Yin JAL: Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method. Leukemia 2001, 15:1060–1065. Residual disease was studied by competitive RT-PCR.

5. Slack JL, Bi W, Livak KJ, et al.: Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction. J Mol Diagn 2001, 3:141–149.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualisierte Therapie der akuten myeloischen Leukämie;Der Onkologe;2012-11-07

2. Nanocolonies and diagnostics of oncological diseases associated with chromosomal translocations;Biochemistry (Moscow);2010-12

3. Use of nanocolonies to detect minimal residual disease in patients with leukemia t(8;12);Molecular Biology;2009-02

4. Use of five-color staining improves the sensitivity of multiparameter flow cytomeric assessment of minimal residual disease in patients with acute myeloid leukemia;Leukemia & Lymphoma;2007-01

5. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications;Cytometry Part B: Clinical Cytometry;2007